Clinical Trials · NCT00005006

Parathyroid Hormone (PTH) With Alendronate for Osteoporosis

CompletedPhase 2Teriparatide (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
Helen Hayes Hospital
Enrollment
140
Start date
Sep 1987
Locations
1 site, United States
Primary endpoint
Study in Osteoporosis
View Teriparatide compound reference